Hollywood's 2026 Recovery Is Real — Q1 Up 23% Over Last Year, Best Pre-April Showing Since COVID

The numbers are in for the first third of 2026, and they don’t look like any year since the pandemic.

Through April 8, 2026, domestic box office has hit $2.113 billion. That’s a 23.5% jump over the same window in 2025, which landed at $1.711 billion. The Hollywood Reporter’s coverage frames it as the strongest January-to-early-April showing since before COVID. For most practical purposes, that means since 2019.

Two things drove the recovery. One was a genuinely better slate than last year. The other was The Super Mario Galaxy Movie, which opened April 1 and is already past $300 million domestic with more runway ahead. Strip Mario out and the recovery is still real, just smaller. With it, we’re looking at a number that’s starting to resemble a normal pre-COVID year.

What Actually Drove the Q1 Bump

Three patterns from the quarter, not in any particular order:

Four-quadrant family films showed up again. This was the big missing ingredient in 2023 and 2024. When Super Mario Galaxy opens to $180M+ domestic in its first weekend and sustains through Easter, you’ve got something the industry could basically stop making for two years and still get away with. Now it can’t.

Mid-budget dramas are finding audiences. Hail Mary, the other title THR flagged as a quarter contributor, is a lower-budget drama that’s outperforming projections. Not every film needs to be a $200M tentpole to make money. That lesson kept getting relearned in 2025 with Sinners and a few others, but 2026 is the year studios seem to actually believe it.

Theatrical windows finally stabilized. The 2021–2024 experiments with simultaneous streaming and 17-day theatrical windows seemed to have settled into a predictable 45-day default for most major releases. Audiences know what “in theaters” means again. The data suggests that clarity translates to ticket sales.

The April Slate Tells the Next Chapter

Per Box Office Mojo’s release calendar and Boxoffice Pro’s April preview, the month ahead is less Mario-heavy but carries two titles that will test specific theses.

Michael (April 24)

Antoine Fuqua’s Michael Jackson biopic has been the month’s most-watched release for eighteen months. Jaafar Jackson, Michael’s nephew, plays the title role. The supporting cast reads serious: Nia Long, Colman Domingo, Laura Harrier, Larenz Tate. Fuqua directing means this won’t be a sanitized Walk the Line clone. His track record (Training Day, Southpaw) suggests he’ll lean into the darker material, which is probably the only way this film can work given how exposed the estate has been in the press.

The interesting question isn’t whether it opens big. It will. The interesting question is whether it has legs past opening weekend, and whether Academy voters pay attention. A music biopic that clears $200M domestic and gets Best Actor attention is the 2024 Maestro or Elvis template; below that, it’s a commercial-only win.

Apex (April 24)

Baltasar Kormákur directs Charlize Theron, Taron Egerton, and Eric Bana in a wilderness thriller set in Australia. Releases on Netflix.

The streaming release is what makes this interesting. A decade ago, Kormákur directing Theron and Egerton on a $60–80M thriller would have been a late-spring theatrical tentpole. Instead it’s going direct to Netflix, day one, no theatrical window. That’s not a new pattern, but it’s worth noting that the pattern hasn’t broken despite theatrical returning to health. Streamers still outbid theatrical for mid-budget action. The economics haven’t flipped back.

The Quieter Side

April’s not just those two. A handful of smaller releases are worth watching:

• Indie distributors (Neon, A24, IFC) have calibrated releases for the post-Mario slowdown in mid-April
• Several holdovers from Q1 are still adding screens rather than dropping out
• The SXSW premieres from March are starting to trickle into limited theatrical in April

What the Recovery Doesn’t Mean

Worth slowing down on the “Hollywood is back” narrative for a second.

23.5% over 2025 is a big number. But 2025 was a structurally weak year. It had a late-winter lull caused by delayed releases and some strike-era production gaps. Comparing to 2025 flatters 2026. A better comparison is to 2019, the last pre-COVID reference year. On that comparison, 2026 is still running 10–15% below, depending on how you adjust for inflation.

The 2026 story isn’t “exceeding 2019.” It’s “back in the neighborhood of 2019.” That’s significant, but it’s not a triumphant return.

The other thing worth noting: the recovery is concentrated. Super Mario Galaxy alone accounts for a meaningful chunk of the Q1 number. If you removed the top three titles from Q1 2026 and compared the rest to Q1 2019’s rest, the gap is larger. The industry is still dependent on a small number of very big films — maybe more than it was in 2019, not less.

What to Watch Through May

A few markers over the next six weeks:

• Whether Michael can cross $150M domestic. If yes, biopics are fully back. If not, it was a one-off for Maestro.
• Whether the 45-day window holds for anything coming out in May
• Whether Cannes (mid-May) produces a festival darling that actually makes it to theaters this summer with traction. The last few years produced high-acclaim Cannes films that underperformed at a theatrical run, a pattern that hurts indie distributors more than it should

The summer slate is also stacked. Nothing from April Q1 shifts unless something major goes wrong with May or June. Right now, the data suggests 2026 ends around $9.0–9.3 billion domestic — near 2019’s $11.4B adjusted, still not quite there, but notably better than 2024’s $8.7B.

What’s Actually New in 2026

The real story isn’t one specific film or franchise. It’s that the pattern from Q1 looks normal in a way we haven’t seen for five years:

• Strong opening for a family tentpole? Check
• Mid-budget dramas finding their audience? Check
• Clear theatrical window driving ticket purchase intent? Check
• A slate that includes award contenders, genre fare, and streamer releases coexisting without cannibalizing? Check

That’s how the theatrical industry looked before COVID. It’s how it’s starting to look again. The question isn’t whether 2026 is the year Hollywood came back. It’s whether the pattern holds through the rest of the year.

Ask again in December.